Pinnacle Wealth Management LLC Has $2.50 Million Holdings in Axon Enterprise, Inc $AXON

Pinnacle Wealth Management LLC lowered its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 30.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,476 shares of the biotechnology company’s stock after selling 1,554 shares during the period. Axon Enterprise accounts for 1.7% of Pinnacle Wealth Management LLC’s portfolio, making the stock its 22nd largest position. Pinnacle Wealth Management LLC’s holdings in Axon Enterprise were worth $2,495,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Stone House Investment Management LLC acquired a new position in Axon Enterprise in the third quarter valued at about $29,000. New Millennium Group LLC bought a new stake in shares of Axon Enterprise in the 3rd quarter valued at about $29,000. Root Financial Partners LLC acquired a new stake in shares of Axon Enterprise in the 3rd quarter valued at approximately $34,000. Darwin Wealth Management LLC acquired a new stake in shares of Axon Enterprise in the 2nd quarter valued at approximately $37,000. Finally, NewSquare Capital LLC boosted its stake in Axon Enterprise by 96.2% during the 2nd quarter. NewSquare Capital LLC now owns 51 shares of the biotechnology company’s stock worth $42,000 after acquiring an additional 25 shares during the last quarter. 79.08% of the stock is owned by institutional investors.

Analyst Ratings Changes

AXON has been the subject of several recent analyst reports. UBS Group lowered their target price on shares of Axon Enterprise from $610.00 to $570.00 and set a “neutral” rating for the company in a research note on Wednesday. Wall Street Zen lowered shares of Axon Enterprise from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. The Goldman Sachs Group lowered their price objective on shares of Axon Enterprise from $940.00 to $800.00 and set a “buy” rating for the company in a research report on Wednesday, November 5th. Craig Hallum reaffirmed a “buy” rating and set a $820.00 price objective on shares of Axon Enterprise in a research note on Wednesday. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Axon Enterprise in a research note on Monday, December 29th. Sixteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $762.93.

Axon Enterprise Price Performance

NASDAQ:AXON opened at $520.18 on Thursday. Axon Enterprise, Inc has a 52-week low of $396.41 and a 52-week high of $885.91. The company has a market cap of $41.05 billion, a P/E ratio of 342.23, a P/E/G ratio of 13.33 and a beta of 1.48. The company has a debt-to-equity ratio of 0.57, a quick ratio of 2.89 and a current ratio of 3.12. The stock’s 50-day simple moving average is $539.22 and its 200 day simple moving average is $628.00.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.55. The business had revenue of $796.72 million for the quarter, compared to the consensus estimate of $755.29 million. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.94%. The firm’s revenue for the quarter was up 38.5% on a year-over-year basis. During the same period in the previous year, the company earned $2.08 earnings per share. As a group, sell-side analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Insiders Place Their Bets

In other Axon Enterprise news, CFO Brittany Bagley sold 2,000 shares of the company’s stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $580.00, for a total value of $1,160,000.00. Following the transaction, the chief financial officer directly owned 103,501 shares in the company, valued at $60,030,580. The trade was a 1.90% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction dated Wednesday, January 7th. The shares were sold at an average price of $619.01, for a total transaction of $6,190,100.00. Following the completion of the transaction, the chief executive officer directly owned 3,100,997 shares in the company, valued at $1,919,548,152.97. The trade was a 0.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 48,040 shares of company stock worth $27,249,338 in the last quarter. Company insiders own 4.40% of the company’s stock.

Axon Enterprise News Roundup

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q4 beat and strong guidance — Axon reported Q4 revenue of ~$797M (+39% YoY) and non‑GAAP EPS $2.15, beating Street estimates; management issued FY26 growth guidance and a 2028 target of $6B in revenue, supporting upside expectations. PR Newswire: Axon reports Q4 2025
• Positive Sentiment: AI is accelerating demand — Management highlighted AI features across devices and software (body cams, evidence management, report drafting), which investors interpreted as boosting SaaS adoption and bookings momentum. Coverage noting the “AI supercharge” reaction: Investopedia: Axon AI story
• Positive Sentiment: Bookings/backlog and retention — Management disclosed a sizable increase in contracted bookings/backlog and a high net revenue retention (~125%), signaling both strong new sales and upsells from existing customers. This underpins longer‑term revenue visibility. MarketBeat: Q4 results & guidance deck
• Neutral Sentiment: Earnings call/transcript available — Investors can review management commentary and Q&A for nuance on federal spending, enterprise demand and AI rollout. Seeking Alpha: Q4 2025 transcript
• Neutral Sentiment: Short‑interest data flagged as anomalous — a February short‑interest entry shows 0 shares / NaN change (likely a reporting error); not meaningful for positioning until clarified.
• Negative Sentiment: Analysts trimmed price targets despite the beat — several firms cut PTs (UBS to $570/neutral; Barclays, Morgan Stanley, Piper reduced PTs but kept overweight views in many cases), which could cap upside and reflect lingering valuation/near‑term risk concerns. Benzinga: analyst PT cuts

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.